Supplementary Figure 1 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
Year: 2025
Type: supplementary-materials
Abstract: This figure entails the selection of HNSCC and LUSC PDX model based on the H-score of EGFR and MET.
Authors: Sun M. Lim, Seong-san Kang, Dong K. Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin Na, Young T. Kim, Mi R. Yun, Jae H. Kim, Youngseon Byeon, Young S. Kim, Jii B. Lee, Min H. Hong, Joshua C. Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung C. Cho
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4408958103